New oral drug treatment for some advanced breast cancer

https://www.facingourrisk.org/XRAY/Oral-SERD-treatment-for-advanced-breast-cancer

Full article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553388/

The FDA has approved a new oral drug called Oserdu for the treatment of HR-positive, HER2-negative advanced breast cancer. A blood test was also approved to help doctors identify patients who would benefit most from this new treatment. (Posted 3/20/23)

Este artículo está disponible en español.

Questions To Ask Your Health Care Provider

Should I have the biomarker test to see if I have an ESR1 mutation?
Would I benefit from treatment with Orserdu?
Do I have other treatment options?

Open Clinical Trials

You can search for clinical trials involving people with HR-positive or ER-positive metastatic breast cancer here.

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.